UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$469M |
| 2 |
Fidelity National Information Services
FIS
|
+$352M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$337M |
| 4 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$316M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$292M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.92B |
| 2 |
UBS Group
UBS
|
+$1.46B |
| 3 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$547M |
| 4 |
Microsoft
MSFT
|
+$461M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.47% |
| 2 | Financials | 6.72% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 5.76% |
| 5 | Industrials | 5.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7226
ACM Research
ACMR
$5.42B
| $8K | ﹤0.01% |
1,719
+1,266
| +279% | +$6.65K |
|
7227
Afya
AFYA
$1.31B
| $8K | ﹤0.01% |
+298
| New | +$7.69K |
|
7228
Artelo Biosciences
ARTL
$2.68M
| $8K | ﹤0.01% |
+13
| New | +$9.91K |
|
7229
Beasley Broadcasting Group
BBGI
$37.8M
| $8K | ﹤0.01% |
125
| – | – |
|
|
CARV
7230
DELISTED
Carver Bancorp
CARV
| $8K | ﹤0.01% |
2,638
-542
| -17% | -$1.7K |
|
7231
CBAK Energy Technology Ltd
CBAT
$44.3M
| $8K | ﹤0.01% |
13,931
+1,538
| +12% | +$1.34K |
|
7232
Cohu
COHU
$2.26B
| $8K | ﹤0.01% |
574
-1,484
| -72% | -$20.6K |
|
7233
Creative Realities
CREX
$41.1M
| $8K | ﹤0.01% |
1,597
+1,596
| +159,600% | +$9.64K |
|
7234
Civeo
CVEO
$345M
| $8K | ﹤0.01% |
554
-175
| -24% | -$3.09K |
|
7235
CVD Equipment Corp
CVV
$50M
| $8K | ﹤0.01% |
2,423
+359
| +17% | +$1.29K |
|
7236
DB Gold Short ETN due Feb 15 2038
DGZ
$1.82M
| $8K | ﹤0.01% |
613
-2,242
| -79% | -$28.4K |
|
7237
Dolphin Entertainment
DLPN
$13.3M
| $8K | ﹤0.01% |
955
+690
| +260% | +$6.79K |
|
7238
Global X E-commerce ETF
EBIZ
$28.4M
| $8K | ﹤0.01% |
+470
| New | +$8.44K |
|
7239
Edesa Biotech
EDSA
$49.2M
| $8K | ﹤0.01% |
180
+42
| +30% | +$1.52K |
|
7240
Gyre Therapeutics
GYRE
$641M
| $8K | ﹤0.01% |
230
+215
| +1,433% | +$11.6K |
|
7241
Hamilton Lane
HLNE
$4.91B
| $8K | ﹤0.01% |
142
-4,068
| -97% | -$239K |
|
7242
MarineMax
HZO
$759M
| $8K | ﹤0.01% |
527
-8,205
| -94% | -$125K |
|
|
KELYB
7243
Kelly Services Class B
KELYB
$765M
| $8K | ﹤0.01% |
350
| – | – |
|
7244
Kentucky First Federal Bancorp
KFFB
$44.2M
| $8K | ﹤0.01% |
1,000
-129
| -11% | -$976 |
|
|
TBHC
7245
DELISTED
The Brand House Collective
TBHC
| $8K | ﹤0.01% |
5,150
-2,219
| -30% | -$3.45K |
|
7246
Koss Corp
KOSS
$34.8M
| $8K | ﹤0.01% |
3,888
+2,239
| +136% | +$4.42K |
|
|
LOAN
7247
Manhattan Bridge Capital
LOAN
$47.5M
| $8K | ﹤0.01% |
1,300
-4,469
| -77% | -$27.9K |
|
7248
Lightbridge
LTBR
$271M
| $8K | ﹤0.01% |
817
+524
| +179% | +$4.28K |
|
7249
Metalpha Technology Holding
MATH
$44.8M
| $8K | ﹤0.01% |
5,059
+645
| +15% | +$697 |
|
7250
IQ ARB Merger Arbitrage ETF
MNA
$252M
| $8K | ﹤0.01% |
252
-1,444
| -85% | -$45.9K |
|
Similar funds
UBS Group's Q3 2019 Portfolio in Review
As of Q3 2019, UBS Group held 8,655 positions worth $260B, up 0.05% from $260B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q3 2019 filing shows 737 new, 4,061 increased, 2,893 reduced and 594 closed positions. Its largest new stake was Invesco S&P Ultra Dividend Revenue ETF: 1,020,769 shares worth $38.5M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 9.5% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2019 buy was Invesco S&P Ultra Dividend Revenue ETF: 1,020,769 shares worth $38.5M.
- UBS Group added most to iShares US Treasury Bond ETF in Q3 2019, an estimated $469M increase.
- UBS Group's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.92B.
- UBS Group fully exited OAKTREE CAPITAL GROUP, LLC in Q3 2019, selling an estimated $172M.
- UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q3 2019.
- UBS Group opened 737 new positions and closed 594 in Q3 2019.
- UBS Group's portfolio value rose 0.05% quarter-over-quarter to $260B.
Based on UBS Group's 13F filing for Q3 2019, filed 14 Nov 2019.